Rachel McMinn - Insider Trading & Ownership

Entity
Individual
Location
C/O Intercept Pharmaceuticals, Inc., 450 W. 15 Th St., Ste. 505, New York, NY
Summary
The estimated net worth of Rachel McMinn is at least $26.5M dollars as of November 25, 2024. Rachel McMinn is the Chief Executive Officer, Director of Neurogene Inc. and owns shares of Neurogene Inc. (NGNE) stock worth about $26.5M.
All Insider Reports
All Insider Reports

Ownership of Rachel McMinn

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NGNE Neurogene Inc. Chief Executive Officer, Director $26.5M +$969K +3.8% Nov 22, 2024

Insider Transactions Reported by Rachel McMinn:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.